TNTamara S. Novik

Tamara S. Novik

*This is an algorithmically generated author record based on publicly available information.

Tamara S. Novik has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Study on the subchronic toxicity of an antiparasitic combined drug from the group of avermectins and pyrethroids on rats

    by V. V. Tokar, M. B. Musaev, T. S. Novik, K. G. Kurochkina, E. I. Koveshnikova, O. I. Tikhomirova, R. K. Alikebedov

    The purpose of the research is to evaluate the subchronic toxicity in rats of a prototype antiparasitic combined drug from the group of avermectins and pyrethroids conditionally named as CA-18. Materials and methods. The subchronic toxicity was studied on mature outbred male rats to whom the test drug CA-18 was applied epicutaneously at doses of 1,000 and 500 mg/kg for 7 days. The above doses were based on vivisection results and were 1/5 and 1/10 of LD 50 that was 5,000 mg/kg. During the drug application period, the animals' condition and behavior, and local reactions were monitored. Body weight gain dynamics, organ mass coefficients, and biochemical and hematological parameters were determined. Macroscopic examination was performed for the organs, cavities, and skin to which the drug was applied. This experiment included a 10-day aftereffect period when the same parameters as above were determined. Statistical data analysis was performed using the analysis of variance, with a two-sided Student's t-test for a simple comparison of the means. Differences were determined at the significance level of 0.05 . Results and discussion. No animal deaths were observed during the study. The rats consistently gained weight with no signs of intoxication observed in either the drug administration or the aftereffect period. Macroscopic examination of organs, cavities, and skin revealed no pathology. The liver, kidney, heart, and spleen mass coefficients did not show statistically significant changes. There were no changes in biochemical or hematological parameters. No lethal or toxic dose could be determined in this experiment; all doses tested were subtoxic. CA-18 was well tolerated in the subchronic toxicity study.

  • Open Access

    Testing new antiparasitic combination drugs based on avermectins and pyrethroids against endo- and ectoparasitosis of cattle

    by M. B. Musaev, В. В. Токарь, T. S. Novik, K. G. Kurochkina, O. I. Tikhomirova, R. K. Alikebedov

    The purpose of the research is to test two new experimental samples of antiparasitic avermectin and pyrethroid combination drugs (CA-7 and KC-3) in a liquid form for dermal application against ixodid ticks and gastrointestinal nematodes of cattle.Materials and methods. The studies were conducted on 137 animals (cows, bulls, and heifers) of the Simmental breed. Of these, 64 animals most infected with ticks and gastrointestinal nematodes were selected for titration of therapeutic doses and divided into 8 experimental groups of 8 animals each. Drug samples were applied epicutaneously in a range of doses that allowed selecting necessary volumes to obtain the maximum therapeutic effect. To compare the results of the drugs against ticks, the remaining 73 animals were treated in parallel with a commercial insectoacaricidal drug widely used at the experiment site. Faecal samples were collected from the test animals before and on day 7 after application for diagnostics. A coproovoscopic examination was conducted using the Fülleborn flotation method with a saturated sodium chloride solution. The average number of gastrointestinal Strongylata eggs in 1 g of faeces was calculated using a counting chamber. After drug applications, the general condition and local reactions were observed, and the tick and gadfly larvae infection of the animals was recorded. A "critical test" was used to process the obtained data and evaluate the drug efficacy against ixodid ticks and nematodes.Results and discussion. The extensive effectiveness (EE) of CA-7 against ixodid ticks was obtained at doses of 0.2; 0.3; 0.4; and 0.5 mg/kg for avermectin C (active substance) or 4.0; 6.0; 8.0 and 10.0 mL/100 of the body weight for the drug, respectively: 0; 37.5; 62.5 and 87.5% with an average decrease in ticks per animal of 33.0; 98.4; 99.4 and 99.9%. CA-7 against gastrointestinal nematodes of cattle in the same doses showed, on average, a decrease in the number of nematode eggs in 1 g of feces, respectively: 65.1; 86.7; 92.4 and 100% with the EE of 50.0; 75.0; 87.5 and 100%. KC-3 when used in the same doses showed the EE against ixodid ticks equal to 0; 50.0; 75.0 and 87.5%, respectively, with a decrease in the number of ticks per animal of 84.6; 88.6; 98.9 and 99.1% and a decrease, on average, in the number of Strongylata eggs in 1 g of feces, respectively, by 73.4; 84.6; 91.5 and 93.8% with the EE 37.5; 75.0; 87.5 and 87.5%. Both drugs showed 100% efficacy against hypoderma at a maximum dose of 0.5 mg/kg of the body weight for avermectin C when applied topically.

  • Open Access

    Assessment of acute toxicity of two antiparasitic combined drugs from the group of avermectins and piretroids

    by V. V. Tokar, M. B. Musaev, T. S. Novik

    The purpose of the research is to assess the acute toxicity in laboratory animals of experimental samples of two antiparasitic combined drugs from the group of avermectins and pyrethroids, conventionally designated as CA-17 and CA-18 (NBC Pharmbiomed LLC).Materials and methods. The present experiment was performed on sexually mature outbred rats and mice (males), to which the studied drugs were administered in two ways, intragastrically and subcutaneously, in a dose range that allows calculating the parameters of acute toxic effects or setting the maximum tolerated dose. The studied preparations were transparent oily liquids containing avermectin C and cyfluthrin in different concentrations. During 14 days, the condition and behavior of the animals were monitored, death and symptoms of intoxication were recorded. Probit analysis was used to calculate LD50 values and other parameters of acute toxic effects of drugs.Results and discussion. The ЛД50 value of CA-17 when administered intragastrically to rats and mice is 6072 (5208 6975) and 4008 (2340 6094) mg/kg, respectively. The ЛД50 value of CA-18 when administered intragastrically to rats and mice is 3716 (3103 4496) and 2929 (1454 3603) mg/kg, respectively. Compared with rats, mice have a species sensitivity to both drugs. Preparations CA-17 and CA-18 for intragastric administration according to the hygienic classification belong to hazard class 3. The ЛД50 value of CA-17 after cutaneous administration to rats and mice is more than 7,500 mg/kg, respectively. Similar indicators for CA-18 for rats and mice are more than 5,000 and 2,500 mg/kg, respectively. According to the parameters of cutaneous toxicity, both drugs belong to hazard class 4.


  • Open Access

    Effects of experimental infection with Trichinella spiralis larvae and Trichinella products on embryonic development of rats

    by G. V. Konovalova, E. I. Koveshnikova, T. S. Novik, S. I. Chukina

    Relevance. The aim of the research is to study the effect of experimental infection of T. spiralis and trichinella products on the embryonic development of rats.Methods. The experiment was conducted on 3 experimental groups of rats with corresponding controls. The effect of chronic trichinella invasion of various durations (40–60 days and 6–8 months) on the embryonic development of rats was studied in rats of groups 1 and 2. The effect of T. spiralis protein extract on the embryonic development of fetuses from rats, which were intraperitoneally injected with the test product during the critical periods of embryogenesis (4th, 11th and 16th days), was studied on animals of the 3rd group.Results. The negative effects of Trichinella infection on development of fetuses were detected only in rats on 40–60 days post infection. A statistically significant increase in average number of resorptions, postimplantation and total embryonic mortality were noted. The preimplantation mortality rates did not differ from the control value. Three fetuses with malformations as edema were detected. However, there were no internal anomalies. When assessing the development of fetuses from rats with Trichinella chronic infection with longer duration (6–8 months) the fetus death rates were comparable to the control ones. No fetuses with external or internal malformations were detected.The tested protein preparation did not show negative effects on the development of embryos. In all variants of the experiment no pathology of skeletal system rudiments was noted.


  • Open Access

    Subchronic toxicity of a drug based on D-cyphenothrin, pyriproxyfen and piperonyl butoxide

    by M. V. Arisov, D. S. Poselov, E. V. Poselova, A. A. Stepanov, T. S. Novik

    The purpose of the research is to study the effects of a combined drug based on D-cyphenothrin, pyriproxyfen and piperonyl butoxide on the body of rats with repeated dermal application in a subchronic experiment.Materials and methods. The drug subchronic toxicity was studied in the vivarium of the VNIIP – FSC VIEV on 30 male rats divided into one control and two experimental groups of 10 animals each. The drug was applied daily for 7 days to the experimental rats at doses of 1/10 and 1/20 of the maximum possible dose for dermal application determined in an acute experiment when studying LD50. On the first day and at 10 days after the last application of the drug, half of the animals from each group were euthanized and blood samples were taken to determine morphological and biochemical parameters. A macroscopic examination of the organs was carried out; their mass was determined, and mass coefficients were calculated.Results and discussion. The drug based on D-cyphenothrin, pyriproxyfen and piperonyl butoxide applied dermally for 7 days in doses of 1/10 of LD50 (3071 mg/kg) and 1/20 of LD50 (1535.5 mg/kg) had no negative effect on the rats' organism, or its physiological state, and caused no changes in the morphological or biochemical blood parameters, as well as the mass coefficients of the internal organs. Doses of 3071 and 1535.5 mg/kg were inactive (safe). The threshold and toxic doses could not be determined


  • Investigation of general toxic effects of Relatox in comparison with Dysport

    by T.S. Novik, E.I. Koveshnikova, K.G. Kurochkina, S.I. Chukina

    Objective. To evaluate the toxic effects of the agent Relatox on mature outbred rats and mice in an acute experiment in comparison with the registered analogue Dysport. Material and methods. Based on the aim of experiment, the acute toxic effects of Relatox and Dysport were assessed on two animal species: rats and mice at intraperitoneal and intramuscular administration at dose levels that made it possible to calculate the toxicological parameter values (initially 10—150 U/kg with subsequent usage of additional doses 20 U/kg to 300 U/kg depending on the agent and route of administration). The LD50 values and other acute toxic parameters were calculated using probit analysis. Results. The manifested intoxication picture was observed following administration of both agents, in which neurological symptoms specific to botulinum toxin came to the fore: muscle paresis and local paralysis, which were the result of the mode of therapeutic action of the toxin. The observed picture of intoxication, monitoring of the dynamics of body weight gains, as well as data of macroscopic analysis of organs and tissues indicate a complete analogy of animal responses to both agents administration. However, the mortality rates of animals differed when administered at different doses as well as the established LD50 values of Relatox and Dysport. Conclusions. Both agents were more toxic when administered intraperitoneally than intramuscularly. Species or gender sensitivities were no detected for both agents. LD50 values of Relatox and Dysport established based on the results of an acute experiment, should be considered taking into account the differences (approximately 2.5—3-folds) in the specific activity of these agents.


  • Open Access

    Sweet-Tasting Natural Proteins Brazzein and Monellin: Safe Sugar Substitutes for the Food Industry

    by Tamara S. Novik, Elena I. Koveshnikova, Anatoly A. Kotlobay, Lyudmila P. Sycheva, Karine G. Kurochkina, Olga A. Averina, Maria V. Belopolskaya, Petr V. Sergiev, Olga A. Dontsova, Vassili N. Lazarev, et al.

    This article presents the results of a comprehensive toxicity assessment of brazzein and monellin, yeast-produced recombinant sweet-tasting proteins. Excessive sugar consumption is one of the leading dietary and nutritional problems in the world, resulting in health complications such as obesity, high blood pressure, and cardiovascular disease. Although artificial small-molecule sweeteners widely replace sugar in food, their safety and long-term health effects remain debatable. Many sweet-tasting proteins, including thaumatin, miraculin, pentadin, curculin, mabinlin, brazzein, and monellin have been found in tropical plants. These proteins, such as brazzein and monellin, are thousands-fold sweeter than sucrose. Multiple reports have presented preparations of recombinant sweet-tasting proteins. A thorough and comprehensive assessment of their toxicity and safety is necessary to introduce and apply sweet-tasting proteins in the food industry. We experimentally assessed acute, subchronic, and chronic toxicity effects, as well as allergenic and mutagenic properties of recombinant brazzein and monellin. Our study was performed on three mammalian species (mice, rats, and guinea pigs). Assessment of animals’ physiological, biochemical, hematological, morphological, and behavioral indices allows us to assert that monellin and brazzein are safe and nontoxic for the mammalian organism, which opens vast opportunities for their application in the food industry as sugar alternatives.


  • Open Access

    Antimitotic effects of Cysticercus tenuicollis protoscolexes extract at administration to mice and their negative consequences for organism

    by T. S. Novik, E. I. Koveshnikova, A. A. Tkhakakhova, S. I. Chukina, L. A. Napisanova, O. N. Andreyanov, A. V. Uspensky

    The purpose of the research is studying of Cysticercus tenuicollis protoscolexes extract effects on cell division at different routes of administration to mice and evaluation of the associated negative effects.Materials and methods. C. tenuicollis were obtained from spontaneously infected sheep in Kabardino-Balkarian Republic. C. tenuicollis protoscolexes were washed, crushed and homogenized. Protein extraction was performed with phosphate buffered saline pH 7.2–7.4. C. tenuicollis extract was administered intraperitoneally and intravenously to mice males at the dose level of 80 μg protein/animal. The control group of mice was intravenously injected with 0.1 ml of saline. At hours 3; 6; 24 and 48 post extract administration mice were euthanized. Bone marrow samples were taken from experimental and control mice for preparation of microscopic preparations to assess mitotic activity in a given cell population. The mitotic index was determined, all stages of mitosis were recorded. At the above time points blood samples were taken from mice to determine the main hematological parameters post intravenous and intraperitoneal administration of C. tenuicollis extract. The main hematological parameters of mice were determined using hematological analyzer MicroCC-20 Plus (High Technology, Inc. (USA)); leukocyte formula – by the generally accepted method. Samples of liver, kidneys, spleen, mesenteric lymph nodes and testes were taken from experimental and control animals for macroscopic and microscopic studies.Results and discussion. C. tenuicollis protoscolices extract leads to inhibition of cell division in the population bone marrow and testes cells in mice when administered intravenously and intraperitoneally at the dose level of 80 μg/animal manifested in accumulation of metaphases and decrease of other stages. At both routes of administration a decrease in leukocyte counts was noted. The observed microscopic changes in testes, spleen and lymph nodes either reflect the consequences of extract antimitotic effect or the immune response to the administration of C. tenuicollis extract.

  • Open Access

    Effects of Trichinella spiralis and Echinococcus multilocularis extracts after single and multiple injections on mitosis and hematological and biochemical parameters of mice

    by T. S. Novik, E. I. Koveshnikova, S. I. Chukina, L. A. Napisanova, O. N. Andreyanov, I. A. Arkhipov, K. G. Kurochkina

    The purpose of the research is to study effects of Trichinella spiralis and Echinococcus multilocularis extracts on mitosis in a bone marrow cell population, and on hematological and biochemical blood parameters of mice after single and multiple intraperitoneal injections.Materials and methods. The experiment was conducted on outbred male mice. The T. spiralis and E. multilocularis extracts were administered intraperitoneally once or multiple times daily for 10 days at a dose of 80 μg/mouse. Bone marrow cell isolation, microscopic preparations, mitotic index and individual stage determination were made as described in the literature (Ford C. E., Hamerton J. L., 1956). The mouse main peripheral blood parameters were determined with a MicroCC-20 Plus hematological analyzer, and the leucogram was determined by a conventional method. Biochemical blood parameters of the mice were determined with a Clima MC-15 analyzer.Results and discussion. The T. spiralis and E. multilocularis extracts after a single intraperitoneal injection at a dose of 80 μg/ mouse had a pronounced negative effect on the mouse bone marrow cell mitosis with the cell division terminated in the metaphase and a decreased proportion of other mitosis stages. Characteristics were detected of the effects made by the T. spiralis and E. multilocularis extracts on the mouse bone marrow cell mitosis after multiple administration for 10 days. In the reinjection mode of the test extracts to the mice, hematological and biochemical parameters did not change.


  • Open Access

    The effect of Farmayod on nematodes of different trophic groups in vitro and in vivo

    by A. N. Konrat, T. S. Novik, A. A. Shesteperov

    The purpose of the research is to study the effect of Farmayod on nematodes of different trophic groups, including rootknot nematode larvae, in vitro and in vivo.Materials and methods. The object of the research were larvae of the root-knot nematode Meloidogyne incognita obtained from the roots of infected plants from the Vladimir Region. The study of the effect of Farmayod in three concentrations was carried out in laboratory, using the biotest method on pumpkin plants. The effect of liquid Farmayod on the viability of nematodes of different trophic groups was studied in vitro and in vivo.Results and discussion. Liquid 0.1% Farmayod showed phytotoxicity, and not a single plant germinated. The drug in the form of a 0.01% solution showed phytotoxicity but to a lesser extent. The root system was less developed (60%) than in the control. The plant height was also 15% less. Farmayod at a concentration of 0.01% did not have phytotoxicity and reduced meloidoginosis versus the control. The biological efficacy of such dose was 56% higher, and the plant height was 30% more. The drug at a concentration of 0.01% had no effect on the plants damaged by meloidoginosis due to its phytotoxicity and poorly developed root system of the plants versus the control. Thus, at low concentrations, Farmayod acts on plants as a trace element necessary for plant vegetation, which affected the size of the plant. On the other hand, it can significantly reduce the infection of pumpkin roots with root-knot nematodes. Since this concentration is not toxic to nematodes, it can be assumed that the drug affects the nematode indirectly through the plant.